Bluewater Bio International, a leading provider of innovative high-performance, cost-effective water and wastewater treatment technologies, is delighted to announce that it has received the accolade of ‘Best Process Technology’ at this year’s prestigious Water and Energy Exchange (“WEX”) Global Innovation Awards. The ceremony, sponsored by Degremont, took place at the illustrious Circulo de Bellas Artes in Madrid during the 8th annual WEX conference, which brings together the world’s leading experts and authorities in the Water and Energy industries. (

The awards were open to organisations that have made a significant contribution to the water and wastewater sector during the previous 12 months. They were fiercely contested, with BwB competing in the process technology category against multi-billion pound nominees such as Sembcorp and Kemira.

Bluewater Bio has recently celebrated the successful commissioning and performance of its HYBrid ACtivated Sludge (“HYBACS”) upgrade at Tubli Water Pollution Control Centre in Bahrain, generating strong ministerial and media endorsement. Just last month, the company welcomed a delegation of 40 key industry personnel from leading water engineering companies around the globe, keen to witness the impressive performance of HYBACS first hand. BwB has now entered into an operation and maintenance contract at Tubli.

Daniel Ishag, Founder and CEO of Bluewater Bio International added: “Our 100 ML/d HYBACS plant at Tubli is the jewel in BwB’s crown, with test results consistently outperforming the client’s expectations. Gaining recognition from not only the client but also the highly respected and esteemed industry peers represented by the WEX awards, is a great honour and one of which the team at BwB should be immensely proud.”

Furthermore, the HYBACS upgrade at Tubli has also been shortlisted for wastewater project of the year in April’s Global Water Intelligence (“GWI”) awards, along with industry heavyweights such as Aqualia, CH2M Hill, Tedagua, Veolia and WTE. (

Daniel concludes: “We must not forget that, in industry terms, Bluewater Bio is still a relatively young company. To be credited so highly, under tough competition from the establishment, is testament to our entrepreneurial commitment, drive and determination. The results of our HYBACS process speak for themselves; we have a compelling technology, proven on a large scale, that I envisage becoming an industry standard over the near term.”